| | | | |
CUSIP No. 817732100 | | SCHEDULE 13D | | Page 3 of 5 |
This Amendment No. 5 (“Amendment No. 5”) to Schedule 13D supplements and amends the Schedule 13D filed on September 30, 2021, as amended by Amendment No. 1 to Schedule 13D filed on December 20, 2021, Amendment No. 2 to Schedule 13D filed on January 4, 2022, Amendment No. 3 to Schedule 13D filed on February 17, 2022 and Amendment No. 4 to Schedule 13D filed on April 6, 2022 (collectively the “Prior Schedule 13D Filings”). Information reported in the Prior Schedule 13D Filings remains in effect except to the extent that it is amended, restated or superseded by information contained in this Amendment No. 5. Unless otherwise indicated, capitalized terms used but not otherwise defined herein shall have the meaning assigned to such terms in the Prior Schedule 13D Filings. Responses to each item of this Amendment No. 5 are incorporated by reference into the response to each other item, as applicable.
Item 3. | Source and Amount of Funds or Other Consideration. |
Item 3 of the Prior Schedule 13D Filings is hereby replaced in its entirety as follows:
All of the shares of Common Stock owned by the Reporting Person were purchased by the Reporting Person with his personal funds. The total consideration paid for the 273,661 shares of Common Stock purchased by the Reporting Person was $3,039,060.
Item 5. | Interest in Securities of the Issuer. |
Item 5(a), (b) and (c) of the Prior Schedule 13D Filings are hereby replaced in their entirety as follows:
(a) and (b) Reporting Person owns beneficially, and has the sole power to vote and dispose of, 273,661 shares of Common Stock or approximately 10.9% of the outstanding shares of Common Stock of the Company, based on 2,510,042 shares of Common Stock outstanding as of November 7, 2022, as set forth in the Company’s Quarterly Report on Form 10-Q for the Quarter ended September 30, 2022.
(c) The transactions in shares of Common Stock by Reporting Person since the date of the filing of Amendment No. 4 to the Schedule 13D were as follows:
| | | | | | |
Nature and Date of Transaction | | Number of Shares of Common Stock Purchased | | Price Per Share ($) | |
Open Market Purchase – 12/12/22 | | 12,000 | | $ | 11.1013 | |
Open Market Purchase – 1/17/23 | | 2,000 | | $ | 11.1394 | |
Open Market Purchase – 1/17/23 | | 2,000 | | $ | 10.972 | |
Open Market Purchase – 1/17/23 | | 1,000 | | $ | 10.77 | |
Open Market Purchase – 1/17/23 | | 1,000 | | $ | 10.9837 | |
Open Market Purchase – 1/17/23 | | 661 | | $ | 11.0596 | |
Open Market Purchase – 1/18/23 | | 1,000 | | $ | 11.6671 | |
Open Market Purchase – 1/18/23 | | 1,000 | | $ | 11.353 | |
Open Market Purchase – 1/18/23 | | 1,000 | | $ | 11.2709 | |
Open Market Purchase – 1/18/23 | | 2,000 | | $ | 11.5639 | |